サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1612861

宿主細胞コンタミナントテストの世界市場：産業分析・規模・シェア・成長・動向・予測 (2024-2031年)

Host Cell Contaminant Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日
ページ情報
英文 198 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
宿主細胞コンタミナントテストの世界市場：産業分析・規模・シェア・成長・動向・予測 (2024-2031年)
出版日: 2024年12月12日
発行: Persistence Market Research
ページ情報: 英文 198 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

主な洞察

  • 宿主細胞コンタミナントテストの市場規模 (2024年)：3億2,830万米ドル
  • 市場規模の予測 (2031年)：4億7,880万米ドル
  • 世界の市場成長率 (2024～2031年)：CAGR 5.5%

市場促進要因：

効率的な宿主細胞コンタミナントテストの需要は、主にバイオ医薬品における品質保証の必要性の高まりによってもたらされています。業界が拡大を続ける中、製品の安全性、有効性、規制遵守の確保が重視されるようになっています。次世代シーケンシングや高分解能質量分析などの検出技術の進歩が正確で信頼性の高い結果を提供することで市場成長をさらに促進しています。また、慢性疾患の増加やバイオシミラー開発の増加により、厳格なコンタミナントテストプロトコルの重要性が高まっています。

市場抑制要因：

有望な成長見通しにもかかわらず、市場は一定の課題に直面しています。特に中小企業や学術機関にとっては、高度な試験や機器に関連する高コスト性が障壁となる可能性があります。さらに、地域間でテストプロトコルが標準化されていないため一貫性がなく、世界なコンプライアンスへの取り組みに影響を及ぼします。これらの要因は、特に費用対効果が重要視される新興国での市場拡大を制限する可能性があります。

市場機会：

この市場には、特にコンタミナントテストプロセスにおける自動化とAIの統合において、大きな事業機会があります。自動化システムはスループットを向上させるだけでなく、人的ミスを最小限に抑え、より高い精度を保証します。バイオ製薬企業と開発業務受託機関のコラボレーションは、効率的なリソースの活用と専門知識の共有を可能にし、もう一つの成長の道を示しています。さらに、世界の規制強化は、より高度で包括的な検査ソリューションの採用を促進すると考えられています。

当レポートでは、世界の宿主細胞コンタミナントテストの市場を調査し、市場の定義と概要、市場促進要因・抑制要因、各種動向、市場機会、課題、市場規模 (金額・一部数量) の推移・予測、各種区分・地域/主要国別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義
  • 市場分類

第3章 宿主細胞コンタミナントテスト：市場機会の分析

  • マクロ経済要因
  • 機会分析
  • 市場力学

第4章 北米の宿主細胞コンタミナントテスト市場の分析・予測

  • 市場規模の推移・予測：国別
    • 米国
    • カナダ
  • 市場規模の推移・予測：製品タイプ別
    • PCRベースのアッセイ
    • ELISAベースのアッセイ
  • 市場規模の推移・予測：プラットフォーム別
    • 微生物
    • 哺乳類
    • その他
  • 市場規模の推移・予測：用途別
    • 研究開発
    • 臨床応用
  • 市場規模の推移・予測：エンドユーザー別
    • バイオ医薬品企業
    • CRO
    • CMO
    • 学術&研究機関
  • 促進要因・抑制要因：影響分析
  • 市場の魅力分析
  • 主要参入企業
  • 市場プレゼンス（強度マップ）

第5章 ラテンアメリカの宿主細胞コンタミナントテスト市場の分析・予測

  • 市場規模の推移・予測：国別
    • ブラジル
    • メキシコ
    • その他
  • 市場規模の推移・予測：製品タイプ別
  • 市場規模の推移・予測：プラットフォーム別
  • 市場規模の推移・予測：用途別
  • 市場規模の推移・予測：エンドユーザー別
  • 促進要因・抑制要因：影響分析
  • 市場の魅力分析
  • 主要参入企業
  • 市場プレゼンス（強度マップ）

第6章 欧州の宿主細胞コンタミナントテスト市場の分析・予測

  • 市場規模の推移・予測：国別
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • その他
  • 市場規模の推移・予測：製品タイプ別
  • 市場規模の推移・予測：プラットフォーム別
  • 市場規模の推移・予測：用途別
  • 市場規模の推移・予測：エンドユーザー別
  • 促進要因・抑制要因：影響分析
  • 市場の魅力分析
  • 主要参入企業
  • 市場プレゼンス（強度マップ）

第7章 アジア太平洋の宿主細胞コンタミナントテスト市場の分析・予測

  • 市場規模の推移・予測：国別
    • 中国
    • 日本
    • インド
    • ASEAN
    • オーストラリア・ニュージーランド
    • その他
  • 市場規模の推移・予測：製品タイプ別
  • 市場規模の推移・予測：プラットフォーム別
  • 市場規模の推移・予測：用途別
  • 市場規模の推移・予測：エンドユーザー別
  • 促進要因・抑制要因：影響分析
  • 市場の魅力分析
  • 主要参入企業
  • 市場プレゼンス（強度マップ）

第8章 中東・アフリカの宿主細胞コンタミナントテスト市場の分析・予測

  • 市場規模の推移・予測：国別
    • GCC諸国
    • 南アフリカ
    • 北アフリカ
    • その他
  • 市場規模の推移・予測：製品タイプ別
  • 市場規模の推移・予測：プラットフォーム別
  • 市場規模の推移・予測：用途別
  • 市場規模の推移・予測：エンドユーザー別
  • 促進要因・抑制要因：影響分析
  • 市場の魅力分析
  • 主要参入企業
  • 市場プレゼンス（強度マップ）

第9章 予測要因：関連性と影響

第10章 予測の前提条件

第11章 競合情勢

  • 競合ダッシュボード
  • 企業プロファイル（詳細：概要、財務、戦略、SWOT、最近の動向）
    • BioGenes GmbH
    • Bio-Rad Laboratories, Inc.
    • Cisbio Bioassays
    • Cygnus Technologies LLC (A Maravai Lifesciences Company)
    • Enzo Life Sciences, Inc.
    • ForteBio (A Pall Company)
    • GE Healthcare Life Sciences
    • Molecular Devices LLC
    • ProteinSimple (A BioTechne Brand)
    • Thermo Fisher Scientific, Inc.

第12章 世界の宿主細胞コンタミナントテスト市場の分析・予測：地域別

第13章 世界の宿主細胞コンタミナントテスト市場の分析・予測：製品タイプ別

第14章 世界の宿主細胞コンタミナントテスト市場の分析・予測：プラットフォーム別

第15章 世界の宿主細胞コンタミナントテスト市場の分析・予測：用途別

第16章 世界の宿主細胞コンタミナントテスト市場の分析・予測：エンドユーザー別

第17章 世界の宿主細胞コンタミナントテスト市場の分析・予測

  • 市場規模・前年比成長率
  • 収益機会

第18章 調査手法

目次
Product Code: PMRREP21355

Persistence Market Research has recently released a comprehensive report on the global host cell contaminant testing market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Host Cell Contaminant Testing Market Size (2024E): US$ 328.3 Mn
  • Projected Market Value (2031F): US$ 478.8 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 5.5%

Host Cell Contaminant Testing Market - Report Scope:

Host cell proteins refer to a diverse group of proteins derived from host cells such as yeast, E. coli, and mammals. These proteins exhibit significant differences in properties, isoelectric points, and molecular masses. The identification and quantification of host cell contaminants are crucial during biopharmaceutical development. A wide array of techniques, including immuno-specific methods like ELISA, Western Blot, and PCR, as well as non-specific methods like electrophoresis and LC-MS, are utilized to ensure the purity of biopharmaceutical samples. The ideal approach combines high throughput and quantitative analysis to identify all types of contaminants effectively.

Market Drivers:

The demand for efficient host cell contaminant testing methods is primarily driven by the growing need for quality assurance in biopharmaceuticals. As the industry continues to expand, there is a heightened emphasis on ensuring the safety, efficacy, and regulatory compliance of products. Advances in detection technologies, such as next-generation sequencing and high-resolution mass spectrometry, further propel market growth by offering precise and reliable results. Additionally, the increasing prevalence of chronic diseases and the rise in biosimilar development are amplifying the importance of rigorous contaminant testing protocols.

Market Restraints:

Despite the promising growth prospects, the market faces certain challenges. High costs associated with advanced testing methods and equipment can act as barriers, especially for smaller companies and academic institutions. Furthermore, the lack of standardization in testing protocols across regions leads to inconsistencies, impacting global compliance efforts. These factors can limit market expansion, particularly in emerging economies where cost-effectiveness is a critical consideration.

Market Opportunities:

The market holds significant opportunities, particularly in the integration of automation and artificial intelligence in contaminant testing processes. Automated systems not only enhance throughput but also minimize human error, ensuring higher accuracy. Collaborations between biopharmaceutical companies and contract research organizations present another growth avenue, enabling efficient resource utilization and expertise sharing. Furthermore, increasing regulatory stringency worldwide is likely to drive the adoption of more advanced and comprehensive testing solutions.

Competitive Intelligence and Business Strategy:

The global host cell contaminant testing market is characterized by the presence of key players focusing on innovation, strategic collaborations, and geographic expansion. Leading companies are investing in research and development to offer cutting-edge solutions, ensuring precision and efficiency in contaminant detection. Partnerships between large-scale pharmaceutical firms and smaller biopharmaceutical entities are fostering market growth, enabling the introduction of novel testing methodologies.

.

Key Companies Profiled:

  • BioGenes GmbH
  • Bio-Rad Laboratories, Inc.
  • Cisbio Bioassays
  • Cygnus Technologies LLC (A Maravai Lifesciences Company)
  • Enzo Life Sciences, Inc.
  • ForteBio (A Pall Company)
  • GE Healthcare Life Sciences
  • Molecular Devices LLC
  • ProteinSimple (A BioTechne Brand)
  • Thermo Fisher Scientific, Inc.
  • Others

Host Cell Contaminant Testing Market Segmentation:

By Product Type:

  • PCR-based Assays
  • ELISA-based Assays

By Platform:

  • Microbial
  • Mammalian
  • Others

By Application:

  • Research & Development
  • Clinical Applications

By End User:

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Contract Manufacturing Organizations
  • Academic & Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Host Cell Contaminant Testing Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis
  • 3.3. Market Dynamics

4. North America Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 4.1. Introduction
  • 4.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 4.2.1. U.S.
    • 4.2.2. Canada
  • 4.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 4.3.1. U.S.
    • 4.3.2. Canada
  • 4.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 4.4.1. PCR-based Assays
    • 4.4.2. ELISA-based Assays
  • 4.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 4.5.1. PCR-based Assays
    • 4.5.2. ELISA-based Assays
  • 4.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 4.6.1. Microbial
    • 4.6.2. Mammalian
    • 4.6.3. Others
  • 4.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 4.7.1. Microbial
    • 4.7.2. Mammalian
    • 4.7.3. Others
  • 4.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 4.8.1. Research & Development
    • 4.8.2. Clinical Applications
  • 4.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 4.9.1. Research & Development
    • 4.9.2. Clinical Applications
  • 4.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 4.10.1. Biopharmaceutical Companies
    • 4.10.2. Contract Research Organizations
    • 4.10.3. Contract Manufacturing Organizations
    • 4.10.4. Academic & Research Institutes
  • 4.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 4.11.1. Biopharmaceutical Companies
    • 4.11.2. Contract Research Organizations
    • 4.11.3. Contract Manufacturing Organizations
    • 4.11.4. Academic & Research Institutes
  • 4.12. Drivers and Restraints: Impact Analysis
  • 4.13. Market Attractiveness Analysis
    • 4.13.1. By Country
    • 4.13.2. By Product Type
    • 4.13.3. By Platform
    • 4.13.4. By Application
    • 4.13.5. By End User
  • 4.14. Key Representative Market Participants
  • 4.15. Market Presence (Intensity Map)

5. Latin America Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 5.1. Introduction
  • 5.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 5.2.1. Brazil
    • 5.2.2. Mexico
    • 5.2.3. Rest of Latin America
  • 5.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 5.3.1. Brazil
    • 5.3.2. Mexico
    • 5.3.3. Rest of Latin America
  • 5.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 5.4.1. PCR-based Assays
    • 5.4.2. ELISA-based Assays
  • 5.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 5.5.1. PCR-based Assays
    • 5.5.2. ELISA-based Assays
  • 5.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 5.6.1. Microbial
    • 5.6.2. Mammalian
    • 5.6.3. Others
  • 5.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 5.7.1. Microbial
    • 5.7.2. Mammalian
    • 5.7.3. Others
  • 5.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 5.8.1. Research & Development
    • 5.8.2. Clinical Applications
  • 5.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 5.9.1. Research & Development
    • 5.9.2. Clinical Applications
  • 5.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 5.10.1. Biopharmaceutical Companies
    • 5.10.2. Contract Research Organizations
    • 5.10.3. Contract Manufacturing Organizations
    • 5.10.4. Academic & Research Institutes
  • 5.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 5.11.1. Biopharmaceutical Companies
    • 5.11.2. Contract Research Organizations
    • 5.11.3. Contract Manufacturing Organizations
    • 5.11.4. Academic & Research Institutes
  • 5.12. Drivers and Restraints: Impact Analysis
  • 5.13. Market Attractiveness Analysis
    • 5.13.1. By Country
    • 5.13.2. By Product Type
    • 5.13.3. By Platform
    • 5.13.4. By Application
    • 5.13.5. By End User
  • 5.14. Key Representative Market Participants
  • 5.15. Market Presence (Intensity Map)

6. Europe Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 6.2.1. Germany
    • 6.2.2. U.K.
    • 6.2.3. France
    • 6.2.4. Italy
    • 6.2.5. Spain
    • 6.2.6. Russia
    • 6.2.7. Rest of Europe
  • 6.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 6.3.1. Germany
    • 6.3.2. U.K.
    • 6.3.3. France
    • 6.3.4. Italy
    • 6.3.5. Spain
    • 6.3.6. Russia
    • 6.3.7. Rest of Europe
  • 6.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 6.4.1. PCR-based Assays
    • 6.4.2. ELISA-based Assays
  • 6.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 6.5.1. PCR-based Assays
    • 6.5.2. ELISA-based Assays
  • 6.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 6.6.1. Microbial
    • 6.6.2. Mammalian
    • 6.6.3. Others
  • 6.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 6.7.1. Microbial
    • 6.7.2. Mammalian
    • 6.7.3. Others
  • 6.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 6.8.1. Research & Development
    • 6.8.2. Clinical Applications
  • 6.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 6.9.1. Research & Development
    • 6.9.2. Clinical Applications
  • 6.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 6.10.1. Biopharmaceutical Companies
    • 6.10.2. Contract Research Organizations
    • 6.10.3. Contract Manufacturing Organizations
    • 6.10.4. Academic & Research Institutes
  • 6.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 6.11.1. Biopharmaceutical Companies
    • 6.11.2. Contract Research Organizations
    • 6.11.3. Contract Manufacturing Organizations
    • 6.11.4. Academic & Research Institutes
  • 6.12. Drivers and Restraints: Impact Analysis
  • 6.13. Market Attractiveness Analysis
    • 6.13.1. By Country
    • 6.13.2. By Product Type
    • 6.13.3. By Platform
    • 6.13.4. By Application
    • 6.13.5. By End User
  • 6.14. Key Representative Market Participants
  • 6.15. Market Presence (Intensity Map)

7. Asia Pacific Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 7.2.1. China
    • 7.2.2. Japan
    • 7.2.3. India
    • 7.2.4. ASEAN
    • 7.2.5. Australia and New Zealand
    • 7.2.6. Rest of Asia Pacific
  • 7.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 7.3.1. China
    • 7.3.2. Japan
    • 7.3.3. India
    • 7.3.4. ASEAN
    • 7.3.5. Australia and New Zealand
    • 7.3.6. Rest of Asia Pacific
  • 7.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 7.4.1. PCR-based Assays
    • 7.4.2. ELISA-based Assays
  • 7.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 7.5.1. PCR-based Assays
    • 7.5.2. ELISA-based Assays
  • 7.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 7.6.1. Microbial
    • 7.6.2. Mammalian
    • 7.6.3. Others
  • 7.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 7.7.1. Microbial
    • 7.7.2. Mammalian
    • 7.7.3. Others
  • 7.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 7.8.1. Research & Development
    • 7.8.2. Clinical Applications
  • 7.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 7.9.1. Research & Development
    • 7.9.2. Clinical Applications
  • 7.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 7.10.1. Biopharmaceutical Companies
    • 7.10.2. Contract Research Organizations
    • 7.10.3. Contract Manufacturing Organizations
    • 7.10.4. Academic & Research Institutes
  • 7.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 7.11.1. Biopharmaceutical Companies
    • 7.11.2. Contract Research Organizations
    • 7.11.3. Contract Manufacturing Organizations
    • 7.11.4. Academic & Research Institutes
  • 7.12. Drivers and Restraints: Impact Analysis
  • 7.13. Market Attractiveness Analysis
    • 7.13.1. By Country
    • 7.13.2. By Product Type
    • 7.13.3. By Platform
    • 7.13.4. By Application
    • 7.13.5. By End User
  • 7.14. Key Representative Market Participants
  • 7.15. Market Presence (Intensity Map)

8. Middle East & Africa Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
    • 8.2.1. GCC Countries
    • 8.2.2. South Africa
    • 8.2.3. North Africa
    • 8.2.4. Rest of MEA
  • 8.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
    • 8.3.1. GCC Countries
    • 8.3.2. South Africa
    • 8.3.3. North Africa
    • 8.3.4. Rest of MEA
  • 8.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 8.4.1. PCR-based Assays
    • 8.4.2. ELISA-based Assays
  • 8.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 8.5.1. PCR-based Assays
    • 8.5.2. ELISA-based Assays
  • 8.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 8.6.1. Microbial
    • 8.6.2. Mammalian
    • 8.6.3. Others
  • 8.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 8.7.1. Microbial
    • 8.7.2. Mammalian
    • 8.7.3. Others
  • 8.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 8.8.1. Research & Development
    • 8.8.2. Clinical Applications
  • 8.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 8.9.1. Research & Development
    • 8.9.2. Clinical Applications
  • 8.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 8.10.1. Biopharmaceutical Companies
    • 8.10.2. Contract Research Organizations
    • 8.10.3. Contract Manufacturing Organizations
    • 8.10.4. Academic & Research Institutes
  • 8.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 8.11.1. Biopharmaceutical Companies
    • 8.11.2. Contract Research Organizations
    • 8.11.3. Contract Manufacturing Organizations
    • 8.11.4. Academic & Research Institutes
  • 8.12. Drivers and Restraints: Impact Analysis
  • 8.13. Market Attractiveness Analysis
    • 8.13.1. By Country
    • 8.13.2. By Product Type
    • 8.13.3. By Platform
    • 8.13.4. By Application
    • 8.13.5. By End User
  • 8.14. Key Representative Market Participants
  • 8.15. Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape

  • 11.1. Competition Dashboard
  • 11.2. Company Profiles (Details - Overview, Financials, Strategy, SWOT, Recent Developments)
    • 11.2.1. BioGenes GmbH
    • 11.2.2. Bio-Rad Laboratories, Inc.
    • 11.2.3. Cisbio Bioassays
    • 11.2.4. Cygnus Technologies LLC (A Maravai Lifesciences Company)
    • 11.2.5. Enzo Life Sciences, Inc.
    • 11.2.6. ForteBio (A Pall Company)
    • 11.2.7. GE Healthcare Life Sciences
    • 11.2.8. Molecular Devices LLC
    • 11.2.9. ProteinSimple (A BioTechne Brand)
    • 11.2.10. Thermo Fisher Scientific, Inc.

12. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Region

  • 12.1. Introduction/Key Findings
  • 12.2. Historical Market Size (US$ Mn ) Trend Analysis By Region, 2019 - 2023
    • 12.2.1. North America
    • 12.2.2. Latin America
    • 12.2.3. Europe
    • 12.2.4. Asia Pacific
    • 12.2.5. Middle East & Africa
  • 12.3. Market Size (US$ Mn ) Forecast By Region, 2024 - 2031
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. Asia Pacific
    • 12.3.5. Middle East & Africa
  • 12.4. Market Attractiveness Analysis By Region

13. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Product Type

  • 13.1. Introduction/Key Findings
  • 13.2. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
    • 13.2.1. PCR-based Assays
    • 13.2.2. ELISA-based Assays
  • 13.3. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
    • 13.3.1. PCR-based Assays
    • 13.3.2. ELISA-based Assays
  • 13.4. Market Attractiveness Analysis By Product Type

14. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Platform

  • 14.1. Introduction/Key Findings
  • 14.2. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
    • 14.2.1. Microbial
    • 14.2.2. Mammalian
    • 14.2.3. Others
  • 14.3. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
    • 14.3.1. Microbial
    • 14.3.2. Mammalian
    • 14.3.3. Others
  • 14.4. Market Attractiveness Analysis By Platform

15. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Application

  • 15.1. Introduction/Key Findings
  • 15.2. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
    • 15.2.1. Research & Development
    • 15.2.2. Clinical Applications
  • 15.3. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
    • 15.3.1. Research & Development
    • 15.3.2. Clinical Applications
  • 15.4. Market Attractiveness Analysis By Application

16. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By End User

  • 16.1.Introduction/Key Findings
  • 16.2. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
    • 16.2.1. Biopharmaceutical Companies
    • 16.2.2. Contract Research Organizations
    • 16.2.3. Contract Manufacturing Organizations
    • 16.2.4. Academic & Research Institutes
  • 16.3. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
    • 16.3.1. Biopharmaceutical Companies
    • 16.3.2. Contract Research Organizations
    • 16.3.3. Contract Manufacturing Organizations
    • 16.3.4. Academic & Research Institutes
  • 16.4. Market Attractiveness Analysis By End User

17. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 17.1. Market Size and Y-o-Y Growth
  • 17.2. Absolute $ Opportunity

18. Research Methodology